The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal

Cell Research

Volumn 20, Issue 4, 2010, Pages 421-433

  Vande Walle, Lieselotte ^a,b   Wirawan, Ellen ^a,b   Lamkanfi, Mohamed ^a,b   Festjens, Nele ^a,b   Verspurten, Jelle ^a,b   Saelens, Xavier ^a,b   Vanden Berghe, Tom ^a,b   Vandenabeele, Peter ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Apoptosis; Ba F3; HtrA2 Omi; IL 3; RIP1

Indexed keywords

BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE CHLOROMETHYL KETONE; PROTEIN BCL 2; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; SERINE PROTEINASE; SERINE PROTEINASE OMI; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL; APOPTOSIS; ARTICLE; CELL LINE; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MITOCHONDRION; MOUSE; PRE B LYMPHOCYTE; RNA INTERFERENCE;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CASPASES; CELL LINE; INTERLEUKIN-3; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PRECURSOR CELLS, B-LYMPHOID; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES;

EID: 77950544208     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.18     Document Type: Article

References (41)

1. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999; 18:6853-6866.
2. Kim JW, Choi EJ, Joe CO. Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene 2000; 19:4491-4499.
3. Lin Y, Devin A, Rodriguez Y, Liu ZG. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 1999; 13:2514-2526. (Pubitemid 29489643)
4. Martinon F, Holler N, Richard C, Tschopp J. Activation of a pro-apoptotic amplification loop through inhibition of NF-κ-Bdependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett 2000; 468:134-136. (Pubitemid 30110782)
5. Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-κ-B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 2005; 280:36560-36566. (Pubitemid 41587731)
6. Hur GM, Lewis J, Yang Q, et al. The death domain kinase RIP has an essential role in DNA damage-induced NF-κ-B activation. Genes Dev 2003; 17:873-882. (Pubitemid 36397375)
7. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF- κ-B signal. Immunity 1998; 8:297-303. (Pubitemid 28188890)
8. Meylan E, Burns K, Hofmann K, et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κ-B activation. Nat Immunol 2004; 5:503-507. (Pubitemid 38660462)
9. Bojes HK, Feng X, Kehrer JP, Cohen GM. Apoptosis in hematopoietic cells (FL5.12) caused by interleukin-3 withdrawal: relationship to caspase activity and the loss of glutathione. Cell Death Differ 1999; 6:61-70. (Pubitemid 29051856)
10. Cornelis S, Bruynooghe Y, Van Loo G, Saelens X, Vandenabeele P, Beyaert R. Apoptosis of hematopoietic cells induced by growth factor withdrawal is associated with caspase-9 mediated cleavage of Raf-1. Oncogene 2005; 24:1552-1562. (Pubitemid 40396085)
11. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997; 91:627-637.
12. Ekert PG, Read SH, Silke J, et al. Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 2004; 165:835-842. (Pubitemid 38821974)
13. Broker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 2005; 11:3155-3162. (Pubitemid 40627860)
14. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 2004; 23:2861-2874. (Pubitemid 38638848)
15. Jones JM, Datta P, Srinivasula SM, et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003; 425:721-727. (Pubitemid 37314315)
16. Martins LM, Morrison A, Klupsch K, et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 2004; 24:9848-9862. (Pubitemid 39458812)
17. Strauss KM, Martins LM, Plun-Favreau H, et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 2005; 14:2099-2111. (Pubitemid 41418010)
18. Hegde R, Srinivasula SM, Zhang Z, et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 2002; 277:432-438. (Pubitemid 34952076)
19. Martins LM, Iaccarino I, Tenev T, et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 2002; 277:439-444. (Pubitemid 34952077)
20. Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001; 8:613-621. (Pubitemid 32946938)
21. van Loo G, van Gurp M, Depuydt B, et al. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 2002; 9:20-26. (Pubitemid 34071990)
22. Verhagen AM, Silke J, Ekert PG, et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 2002; 277:445-454. (Pubitemid 34952078)
23. Yang QH, Church-Hajduk R, Ren J, Newton ML, Du C. Omi/ HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 2003; 17:1487-1496. (Pubitemid 36734706)
24. Trencia A, Fiory F, Maitan MA, et al. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15. J Biol Chem 2004; 279:46566-46572. (Pubitemid 39518301)
25. Cilenti L, Soundarapandian MM, Kyriazis GA, et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem 2004; 279:50295-50301. (Pubitemid 39577845)
26. Devin A, Lin Y, Liu ZG. The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogenactivated protein kinases. EMBO Rep 2003; 4:623-627. (Pubitemid 36939955)
27. Yuasa T, Ohno S, Kehrl JH, Kyriakis JM. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J Biol Chem 1998; 273:22681-22692. (Pubitemid 28399839)
28. Walensky LD. BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ 2006; 13:1339-1350.
29. Johnson DE. Regulation of survival pathways by IL-3 and induction of apoptosis following IL-3 withdrawal. Front Biosci 1998; 3:d313-324.
30. Besancon F, Atfi A, Gespach C, Cayre YE, Bourgeade MF. Evidence for a role of NF-κ-B in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/ platelet-derived growth factor receptor beta fusion protein. Proc Natl Acad Sci USA 1998; 95:8081-8086. (Pubitemid 28326069)
31. Nakata S, Matsumura I, Tanaka H, et al. NF-κ-B family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. J Biol Chem 2004; 279:55578-55586. (Pubitemid 40066561)
32. Li CY, Zhan YQ, Xu CW, et al. EDAG regulates the proliferation and differentiation of hematopoietic cells and resists cell apoptosis through the activation of nuclear factor-κ-B. Cell Death Differ 2004; 11:1299-1308.
33. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW. Apoptosis overrides survival signals through a caspasemediated dominant-negative NF-κ-B loop. Nat Cell Biol 1999; 1:227-233. (Pubitemid 129500942)
34. Nagata Y, Moriguchi T, Nishida E, Todokoro K. Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood 1997; 90:929-934. (Pubitemid 27314124)
35. Nagata Y, Nishida E, Todokoro K. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin- 3. Blood 1997; 89:2664-2669. (Pubitemid 27172550)
36. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11:372-377. (Pubitemid 32900529)
37. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2:717-726. (Pubitemid 37361787)
38. Yu C, Minemoto Y, Zhang J, et al. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 2004; 13:329-340. (Pubitemid 38229806)
39. Vande Walle L, Van Damme P, Lamkanfi M, et al. Proteomewide Identification of HtrA2/Omi Substrates. J Proteome Res 2007; 6:1006-1015.
40. Vercammen D, Brouckaert G, Denecker G, et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998; 188:919-930. (Pubitemid 28433418)
41. Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S, Beyaert R. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell 2000; 5:597-605.